Cuevas Medek Exercises to Improve Postural Control and Balance in Children With Spastic Cerebral Palsy

February 4, 2026 updated by: Riphah International University

Effects of Cuevas Medek Exercises on Postural Control and Balance in Children With Spastic Cerebral Palsy

This study aims to evaluate the effects of Cuevas Medek Exercises on postural control and balance in children with spastic cerebral palsy. Children meeting the eligibility criteria will be randomly allocated into two groups receiving Cuevas Medek Exercises or conventional therapy. The outcomes will be assessed before and after the intervention period to determine the effectiveness of the intervention.

Study Overview

Detailed Description

Spastic cerebral palsy is a common condition characterized by impaired postural control, poor balance, and limitations in functional movement, which affect a child's ability to maintain stability during daily activities. Conventional physiotherapy is commonly used to address these impairments through strengthening, stretching, and task-based exercises, with variable functional outcomes.

Cuevas Medek Exercises is a dynamic therapeutic approach that focuses on activating automatic postural responses and balance reactions through progressively challenging activities with minimal external support. While this approach has shown potential benefits in improving motor control and postural responses, evidence comparing its effects on postural control and balance with conventional therapy in children with spastic cerebral palsy remains limited.

Therefore, a randomized controlled trial is needed to compare the effects of Cuevas Medek Exercises and conventional therapy on postural control and balance in children with spastic cerebral palsy, with the aim of providing evidence to support clinical decision-making in pediatric physiotherapy

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab Province
      • Bhalwal, Punjab Province, Pakistan, 44011
        • Recruiting
        • Tehsil Headquarter Bhalwal
        • Contact:
        • Principal Investigator:
          • Rimsha Waheed, MS-PTT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with spastic diplegic cerebral palsy
  • GMFCS Level III to V
  • Modified Ashworth Scale ≤ 2
  • Able to follow simple commands

Exclusion Criteria:

  • Severe cognitive impairment
  • Uncontrolled epilepsy or frequent seizures
  • Visual or hearing impairment limiting treatment
  • History of recent orthopedic or neurosurgical procedures
  • Other neurological disorders (genetic syndromes, traumatic brain injury)
  • Participation in other experimental therapies during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cuevas medek exercise
Children in this group will receive Cuevas Medek Exercises focusing on activation of postural responses and balance control through progressively challenging activities during the intervention period
Children will receive Cuevas Medek Exercises 3 sessions per week, at an appropriate effort level guided by the therapist, each session lasting 30 minutes, focusing on dynamic postural activation, balance reactions, and functional movement tasks
Other Names:
  • CME
Active Comparator: Conventional therapy
Children in this group will receive conventional physiotherapy including stretching, strengthening, and task-oriented activities aimed at improving postural control and balance
Children will receive conventional physiotherapy 3 sessions per week, at moderate effort suitable for age and condition, each session 30 minutes long, including stretching, strengthening, and task-oriented activities to improve postural control and balance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural Control
Time Frame: At the end of 4 weeks of intervention
Changes from baseline in postural control will be assessed using the Posture and Postural Ability Scale (PPAS). The scale evaluates the child's ability to maintain posture during functional tasks and measures automatic postural responses. The PPAS consists of several domains including trunk control, limb alignment, and dynamic balance. The scoring ranges from 0 to 30, where 0 indicates no disability and 30 indicates maximum postural impairment.
At the end of 4 weeks of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: At the end of 4 weeks of intervention
Changes from baseline in balance will be assessed using the Pediatric Balance Scale (PBS). The PBS evaluates balance in sitting, standing, and during functional tasks such as reaching and turning. The scale consists of 14 items, each scored from 0 to 4, giving a total score ranging from 0 (poor balance) to 56 (excellent balance).
At the end of 4 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayesha Bashir, PhD, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 15, 2026

Study Registration Dates

First Submitted

February 4, 2026

First Submitted That Met QC Criteria

February 4, 2026

First Posted (Actual)

February 11, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spastic Cerebral Palsy (sCP)

Clinical Trials on Cuevas medek exercises

Subscribe